Kawasaki, Japan

Keiichi Ajito



Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 67(Granted Patents)


Location History:

  • Yokohama, JP (2001 - 2004)
  • Kanagawa-Ken, JP (2009)
  • Kawasaki, JP (2003 - 2011)
  • Kanagawa, JP (1993 - 2012)

Company Filing History:


Years Active: 1993-2012

Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Keiichi Ajito: Innovator in Antimicrobial Compounds

Introduction

Keiichi Ajito is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of antimicrobial agents, holding a total of 16 patents. His work focuses on developing compounds that are effective against resistant bacterial strains, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest patents is a 10-azalide compound featuring a 4-membered ring structure. This compound is crosslinked at the 10- and 12-positions and is effective against erythromycin-resistant bacteria, including resistant pneumococci and streptococci. Another notable patent involves lincomycin derivatives, which are novel compounds that demonstrate potent activity against resistant pneumococci. These compounds can be utilized as antimicrobial agents, proving useful in the prevention and treatment of bacterial infectious diseases.

Career Highlights

Throughout his career, Keiichi Ajito has worked with reputable companies such as Meiji Seika Kaisha, Ltd. and Sagami Chemical Research Center. His experience in these organizations has allowed him to refine his expertise in the development of antimicrobial compounds.

Collaborations

Keiichi has collaborated with notable coworkers, including Mikio Yamamoto and Shuichi Gomi. Their combined efforts have contributed to the advancement of innovative solutions in the field of antimicrobial research.

Conclusion

Keiichi Ajito's work in developing effective antimicrobial agents highlights his significant role in addressing bacterial resistance. His numerous patents and collaborations reflect his dedication to innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…